https://www.selleckchem.com/pr....oducts/4-chloro-dl-p
We describe the case of a patient hospitalized for the second time in a month due to delayed worsening of lung lesions in COVID-19 infection without bacterial superinfection. He was treated with hydroxychloroquine, IV dexamethasone and ruxolitinib with rapid improvement of respiratory failure; 1 month after the second discharge, maintaining low-dose oral prednisone, lung consolidations were significantly reduced on control CT. Modulation of immune over-response in late phases of COVID-19 can influence global outcome.Ru
Like
Comment
Share
